Rosenbaum K, Jahnke K, Curti B, Hagen W R, Schnackerz K D, Vanoni M A
Theodor-Boveri-Institut für Biowissenschaften, Physiologische Chemie I, Universität Würzburg, Germany.
Biochemistry. 1998 Dec 15;37(50):17598-609. doi: 10.1021/bi9815997.
Dihydropyrimidine dehydrogenase catalyzes, in the rate-limiting step of the pyrimidine degradation pathway, the NADPH-dependent reduction of uracil and thymine to dihydrouracil and dihydrothymine, respectively. The porcine enzyme is a homodimeric iron-sulfur flavoprotein (2 x 111 kDa). C671, the residue postulated to be in the uracil binding site and to act as the catalytically essential acidic residue of the enzyme oxidative half-reaction, was replaced by an alanyl residue. The mutant enzyme was overproduced in Escherichia coli DH5alpha cells, purified to homogeneity, and characterized in comparison with the wild-type species. An extinction coefficient of 74 mM-1 cm-1 was determined at 450 nm for the wild-type and mutant enzymes. Chemical analyses of the flavin, iron, and acid-labile sulfur content of the enzyme subunits revealed similar stoichiometries for wild-type and C671A dihydropyrimidine dehydrogenases. One FAD and one FMN per enzyme subunit were found. Approximately 16 iron atoms and 16 acid-labile sulfur atoms were found per wild-type and mutant enzyme subunit. The C671A dihydropyrimidine dehydrogenase mutant exhibited approximately 1% of the activity of the wild-type enzyme, thus preventing its steady-state kinetic analysis. Therefore, the ability of the C671A mutant and, for comparison, of the wild-type enzyme species to interact with reaction substrates, products, or their analogues were studied by absorption spectroscopy. Both enzyme forms did not react with sulfite. The wild-type and mutant enzymes were very similar to each other with respect to the spectral changes induced by binding of the reaction product NADP+ or of its nonreducible analogue 3-aminopyridine dinucleotide phosphate. Uracil also induced qualitatively and quantitatively similar absorbance changes in the visible region of the absorbance spectrum of the two enzyme forms. However, the calculated Kd of the enzyme-uracil complex was significantly higher for the C671A mutant (9.1 +/- 0.7 microM) than for the wild-type dihydropyrimidine dehydrogenase (0.7 +/- 0.09 microM). In line with these observations, the two enzyme forms behaved in a similar way when titrated anaerobically with a NADPH solution. Addition of an up to 10-fold excess of NADPH to both dihydropyrimidine dehydrogenase forms led to absorbance changes consistent with reduction of approximately 0.5 flavin per subunit, with no indication of reduction of the enzyme iron-sulfur clusters. Absorbance changes consistent with reduction of both enzyme flavins were obtained by removing NADP+ with a NADPH-regenerating system. On the contrary, the two enzyme species differed significantly with respect to their reactivity with dihydrouracil. Addition of dihydrouracil to the wild-type enzyme species, under anaerobic conditions, led to absorbance changes that could be interpreted to result from both partial flavin reduction and the formation of a complex between the enzyme and (dihydro)uracil. In contrast, only spectral changes consistent with formation of a complex between the oxidized enzyme and dihydrouracil were observed when a C671A mutant enzyme solution was titrated with this compound. Furthermore, enzyme-monitored turnover experiments were carried out anaerobically in the presence of a limiting amount of NADPH and excess uracil with the two enzyme forms in a stopped-flow apparatus. These experiments directly demonstrated that the substitution of an alanyl residue for C671 in dihydropyrimidine dehydrogenase specifically prevents enzyme-catalyzed reduction of uracil. Finally, sequence analysis of dihydropyrimidine dehydrogenase revealed that it exhibits a modular structure; the N-terminal region, similar to the beta subunit of bacterial glutamate synthases, is proposed to be responsible for NADPH binding and oxidation with reduction of the FAD cofactor of dihydropyrimidine dehydrogenase. The central region, similar to the FMN subunit of dihydroorotate dehydrogenases, is likely to harbor the site o
二氢嘧啶脱氢酶在嘧啶降解途径的限速步骤中,催化尿嘧啶和胸腺嘧啶分别依赖NADPH还原为二氢尿嘧啶和二氢胸腺嘧啶。猪的该酶是一种同二聚体铁硫黄素蛋白(2×111 kDa)。假定位于尿嘧啶结合位点并作为该酶氧化半反应催化必需酸性残基的C671被丙氨酸残基取代。突变酶在大肠杆菌DH5α细胞中过量表达,纯化至同质,并与野生型进行比较表征。野生型和突变酶在450 nm处的消光系数测定为74 mM-1 cm-1。对酶亚基的黄素、铁和酸不稳定硫含量进行化学分析,结果表明野生型和C671A二氢嘧啶脱氢酶的化学计量比相似。每个酶亚基发现一个FAD和一个FMN。每个野生型和突变酶亚基发现约16个铁原子和16个酸不稳定硫原子。C671A二氢嘧啶脱氢酶突变体的活性约为野生型酶的1%,因此无法进行其稳态动力学分析。因此,通过吸收光谱研究了C671A突变体以及作为对照的野生型酶与反应底物、产物或其类似物相互作用的能力。两种酶形式均不与亚硫酸盐反应。就反应产物NADP+或其不可还原类似物3-氨基吡啶二核苷酸磷酸结合诱导的光谱变化而言,野生型和突变酶彼此非常相似。尿嘧啶在两种酶形式的吸收光谱可见光区域也诱导了定性和定量相似的吸光度变化。然而,C671A突变体(9.1±0.7 microM)的酶-尿嘧啶复合物的计算解离常数Kd显著高于野生型二氢嘧啶脱氢酶(0.7±0.09 microM)。与这些观察结果一致,当用NADPH溶液厌氧滴定两种酶形式时,它们的行为相似。向两种二氢嘧啶脱氢酶形式中加入高达10倍过量的NADPH会导致吸光度变化,这与每个亚基约0.5个黄素的还原一致,没有迹象表明酶铁硫簇被还原。通过用NADPH再生系统去除NADP+,获得了与两种酶黄素还原一致的吸光度变化。相反,两种酶形式与二氢尿嘧啶的反应性差异显著。在厌氧条件下,向野生型酶中加入二氢尿嘧啶会导致吸光度变化,这可以解释为部分黄素还原以及酶与(二氢)尿嘧啶形成复合物的结果。相比之下,当用该化合物滴定C671A突变酶溶液时,仅观察到与氧化酶和二氢尿嘧啶形成复合物一致的光谱变化。此外,在停流装置中,在有限量的NADPH和过量尿嘧啶存在下,对两种酶形式进行厌氧酶监测周转实验。这些实验直接证明,二氢嘧啶脱氢酶中用丙氨酸残基取代C671会特异性地阻止酶催化的尿嘧啶还原。最后,二氢嘧啶脱氢酶的序列分析表明它具有模块化结构;N端区域类似于细菌谷氨酸合酶的β亚基,被认为负责NADPH结合和氧化以及二氢嘧啶脱氢酶FAD辅因子的还原。中央区域类似于二氢乳清酸脱氢酶的FMN亚基,可能包含该位点。